{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:44:51Z","timestamp":1777045491403,"version":"3.51.4"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1097\/md.0000000000001013","type":"journal-article","created":{"date-parts":[[2015,6,19]],"date-time":"2015-06-19T10:31:41Z","timestamp":1434709901000},"page":"e1013","source":"Crossref","is-referenced-by-count":36,"title":["Combination Therapy of Metformin and Statin May Decrease Hepatocellular Carcinoma Among Diabetic Patients in Asia"],"prefix":"10.1097","volume":"94","author":[{"given":"Hsin-Hung","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Chia","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Hsin","family":"Muo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Yin","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fung-Chang","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Hung","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-38-20210226","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1056\/NEJM195903052601007","article-title":"Diabetes and cancer.","volume":"260","author":"Joslin","year":"1959","journal-title":"N Engl J Med"},{"key":"R2-38-20210226","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2337\/dc10-0666","article-title":"Diabetes and cancer: a consensus report.","volume":"33","author":"Giovannucci","year":"2010","journal-title":"Diabetes Care"},{"key":"R3-38-20210226","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1677\/ERC-09-0087","article-title":"Diabetes and cancer.","volume":"16","author":"Vigneri","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"R4-38-20210226","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2337\/diacare.27.7.1605","article-title":"Mortality and causes of death in a national sample of diabetic patients in Taiwan.","volume":"27","author":"Tseng","year":"2004","journal-title":"Diabetes Care"},{"key":"R5-38-20210226","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2337\/dc09-0453","article-title":"Relationship between carotid intima-media thickness and silent cerebral infarction in Japanese subjects with type 2 diabetes.","volume":"33","author":"Nomura","year":"2010","journal-title":"Diabetes Care"},{"key":"R6-38-20210226","first-page":"465","article-title":"Diabetes mellitus: a true independent risk factor for hepatocellular carcinoma Hepatobiliary Pancreat Dis I","volume":"8","author":"Gao","year":"2009","journal-title":"nt"},{"key":"R7-38-20210226","first-page":"945","article-title":"Diabetes mellitus and primary hepatocellular carcinoma.","volume":"61","author":"Lawson","year":"1986","journal-title":"Q J Med"},{"key":"R8-38-20210226","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jdiacomp.2010.06.004","article-title":"Substantially increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis of epidemiologic evidence in Japan.","volume":"24","author":"Noto","year":"2010","journal-title":"J Diabetes Complications"},{"key":"R9-38-20210226","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/gut.2004.052167","article-title":"Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study.","volume":"54","author":"Davila","year":"2005","journal-title":"Gut"},{"key":"R10-38-20210226","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3748\/wjg.15.280","article-title":"Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management.","volume":"15","author":"Garcia-Compean","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R11-38-20210226","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/hep.1840190312","article-title":"Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis.","volume":"19","author":"Petrides","year":"1994","journal-title":"Hepatology"},{"key":"R12-38-20210226","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1053\/gast.2002.34168","article-title":"Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.","volume":"123","author":"Bugianesi","year":"2002","journal-title":"Gastroenterology"},{"key":"R13-38-20210226","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/gut.2004.052167","article-title":"Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study.","volume":"54","author":"Davila","year":"2005","journal-title":"Gut"},{"key":"R14-38-20210226","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/MAJ.0b013e3182639c26","article-title":"The impact of statin and macrolide use on early survival in patients with Pneumococcal pneumonia.","volume":"345","author":"Doshi","year":"2013","journal-title":"Am J Med Sci"},{"key":"R15-38-20210226","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/eurheartj\/ehl445","article-title":"A review of high-dose statin therapy: targeting cholesterol and inflammation in atherosclerosis.","volume":"28","author":"Patel","year":"2007","journal-title":"Eur Heart J"},{"key":"R16-38-20210226","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jhep.2005.04.010","article-title":"Cell cycle arrest and apoptosis induction in hepatocellular carcinoma cells by HMG-CoA reductase inhibitors: synergistic antiproliferative action with ligands of the peripheral benzodiazepine receptor.","volume":"43","author":"Sutter","year":"2005","journal-title":"J Hepatol"},{"key":"R17-38-20210226","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/bjc.1998.94","article-title":"Suppression by pravastatin, an inhibitor of p21ras isoprenylation, of hepatocarcinogenesis induced by N-nitrosomorpholine in Sprague-Dawley rats.","volume":"77","author":"Tatsuta","year":"1998","journal-title":"Br J Cancer"},{"key":"R18-38-20210226","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000156702","article-title":"Chemoembolization combined with pravastatin improves survival in patients with hepatocellular carcinoma.","volume":"78","author":"Graf","year":"2008","journal-title":"Digestion"},{"key":"R19-38-20210226","first-page":"1055","article-title":"Potential antitumor effects of statins.","volume":"23","author":"Jakobisiak","year":"2003","journal-title":"Int J Oncol"},{"key":"R20-38-20210226","first-page":"2067","article-title":"Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin.","volume":"7","author":"Wong","year":"2001","journal-title":"Clin Cancer Res"},{"key":"R21-38-20210226","first-page":"2898","article-title":"Role of the Raf signal transduction cascade in the in vitro resistance to the anticancer drug doxorubicin.","volume":"7","author":"Weinstein-Oppenheimer","year":"2001","journal-title":"Clin Cancer Res"},{"key":"R22-38-20210226","first-page":"3949","article-title":"HMG CoA reductase inhibitor fluvastatin arrests the development of implanted hepatocarcinoma in rats.","volume":"23","author":"Paragh","year":"2003","journal-title":"Anticancer Res"},{"key":"R23-38-20210226","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jacl.2012.01.009","article-title":"Evaluation of short-term safety and efficacy of HMG-CoA reductase inhibitors in hypercholesterolemic patients with elevated serum alanine transaminase concentrations: PITCH study (PITavastatin versus atorvastatin to evaluate the effect on patients with hypercholesterolemia and mild to moderate hepatic damage).","volume":"6","author":"Han","year":"2012","journal-title":"J Clin Lipidol"},{"key":"R24-38-20210226","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10654-013-9806-y","article-title":"Statin use and risk of hepatocellular carcinoma.","volume":"28","author":"Lai","year":"2013","journal-title":"Eur J Epidemiol"},{"key":"R25-38-20210226","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/ajg.2010.475","article-title":"Statin use and the risk of liver cancer: a population-based case-control study.","volume":"106","author":"Chiu","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"R26-38-20210226","doi-asserted-by":"crossref","first-page":"e71583","DOI":"10.1371\/journal.pone.0071583","article-title":"Metformin therapy and risk of cancer in patients with type 2 diabetes: systematic review.","volume":"8","author":"Franciosi","year":"2013","journal-title":"PLoS ONE"},{"key":"R27-38-20210226","doi-asserted-by":"crossref","first-page":"e33411","DOI":"10.1371\/journal.pone.0033411","article-title":"Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis.","volume":"7","author":"Noto","year":"2012","journal-title":"PLoS ONE"},{"key":"R28-38-20210226","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1210\/jc.2012-1267","article-title":"Kip metformin for liver cancer prevention in patients with type 2 diabetes: a systematic review and meta-analysis.","volume":"97","author":"Zhang","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R29-38-20210226","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/1940-6207.CAPR-10-0157","article-title":"Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.","volume":"3","author":"Decensi","year":"2010","journal-title":"Cancer Prev Res (Phila)"},{"key":"R30-38-20210226","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1038\/oby.2010.21","article-title":"Effects of metformin and weight loss on serum alanine aminotransferase activity in the diabetes prevention program.","volume":"18","author":"Krakoff","year":"2010","journal-title":"Obesity (Silver Spring)"},{"issue":"suppl 2","key":"R31-38-20210226","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1007\/s001250051387","article-title":"The insulin signalling system and the IRS proteins.","volume":"40","author":"White","year":"1997","journal-title":"Diabetologia"},{"key":"R32-38-20210226","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1158\/2159-8290.CD-12-0263","article-title":"Investigating metformin for cancer prevention and treatment: the end of the beginning.","volume":"2","author":"Pollak","year":"2012","journal-title":"Cancer Discov"},{"key":"R33-38-20210226","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/mc.20637","article-title":"Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase.","volume":"49","author":"Hosono","year":"2010","journal-title":"Mol Carcinog"},{"key":"R34-38-20210226","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1158\/1940-6207.CAPR-11-0536","article-title":"Metformin reduces endogenous reactive oxygen species and associated DNA damage.","volume":"5","author":"Algire","year":"2012","journal-title":"Cancer Prev Res (Phila)"},{"key":"R35-38-20210226","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1158\/1055-9965.EPI-11-0992-T","article-title":"Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis.","volume":"21","author":"Bodmer","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R36-38-20210226","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.2337\/dc13-0708","article-title":"Metformin and the incidence of cancer in patients with diabetes: a nested case-control study.","volume":"36","author":"Wang","year":"2013","journal-title":"Diabetes Care"},{"key":"R37-38-20210226","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1158\/0008-5472.CAN-06-1712","article-title":"Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.","volume":"67","author":"Zhang","year":"2007","journal-title":"Cancer Res"},{"key":"R38-38-20210226","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jso.23069","article-title":"Cancer stem cells and their potential implications for the treatment of solid tumors.","volume":"106","author":"Grotenhuis","year":"2012","journal-title":"J Surg Oncol"},{"key":"R39-38-20210226","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.3892\/ijo.2013.2077","article-title":"Low concentration of metformin induces a p53-dependent senescence in hepatoma cells via activation of the AMPK pathway.","volume":"43","author":"Yi","year":"2013","journal-title":"Int J Oncol"},{"key":"R40-38-20210226","doi-asserted-by":"crossref","first-page":"125","DOI":"10.4093\/dmj.2013.37.2.125","article-title":"The relationship between metformin and cancer in patients with type 2 diabetes.","volume":"37","author":"Chung","year":"2013","journal-title":"Diabetes Metab J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000001013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:45:29Z","timestamp":1620960329000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201506030-00038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":40,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000001013","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]}}}